Home›Companies›Biotech & Pharma›Metabolics Pharma

Metabolics Pharma, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 19, 2024·Suggest an edit

About Metabolics Pharma

Metabolics Pharma is a private company based in Philadelphia, Pennsylvania, incorporated in 2024 in Delaware. It has reported $5,526,626 raised in one offering on Form D since September 2024. Its chief executive is Richard Larson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 5, 2024Sep 19, 2024$5,526,626of $6.2M target7$789KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Metabolics Pharma's Form D filed Sep 19, 2024.

MK
Mark Kamp
Director
JD
John Dessouki
Executive officer and director
MF
Mark Finn
Director
Also a director at Enterin.
BM
Barry Miller
Director
Also a director at Enterin.
JB
Jay Brammer
Director
Also a director at Enterin.
RL
Richard Larson
Chief Executive Officer and director
Also an executive officer at Enterin.

Sources

  1. SECMetabolics Pharma, Inc. filing history